Consort Medical plc (CSRT.L) (LON:CSRT) Stock Price Up 0.5% – Still a Buy?

Consort Medical plc (CSRT.L) (LON:CSRT) shot up 0.5% on Thursday . The company traded as high as GBX 1,010 ($12.80) and last traded at GBX 1,010 ($12.80). 768 shares were traded during mid-day trading, a decline of 100% from the average session volume of 520,697 shares. The stock had previously closed at GBX 1,005 ($12.74).

Consort Medical plc (CSRT.L) Price Performance

The company has a debt-to-equity ratio of 55.58, a current ratio of 1.83 and a quick ratio of 1.16. The firm has a market capitalization of £504.60 million and a PE ratio of 127.85. The company has a 50-day moving average price of GBX 1,010 and a 200-day moving average price of GBX 1,010.

About Consort Medical plc (CSRT.L)

Consort Medical plc operates as a one-stop developer and manufacturer of drugs and premium drug delivery devices. It operates through two divisions, Bespak and Aesica. The company provides various life improving treatments to patients across worldwide through the design, development, and manufacture of medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products.